Andraos, E., Dignac, J., & Meggetto, F. (2021). NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target. Cancers (Basel).
Style de citation ChicagoAndraos, Elissa, Joséphine Dignac, et Fabienne Meggetto. "NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target." Cancers (Basel) 2021.
Style de citation MLAAndraos, Elissa, Joséphine Dignac, et Fabienne Meggetto. "NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target." Cancers (Basel) 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.